1. Home
  2. COYA

as 09-12-2025 1:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Founded: 2020 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 107.0M IPO Year: 2022
Target Price: $16.50 AVG Volume (30 days): 96.0K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.25 EPS Growth: N/A
52 Week Low/High: $4.65 - $10.24 Next Earning Date: 11-05-2025
Revenue: $423,452 Revenue Growth: -95.57%
Revenue Growth (this year): -16.91% Revenue Growth (next year): -66.32%

COYA Daily Stock ML Predictions

Share on Social Networks: